Digital Genome Market Outlook 2017-2024| Prominent Players: Sigma-Aldrich, Thermo Fisher Scientific, PerkinElmer, Inc., QIAGEN, BioMarin Pharmaceutical Inc., Illumina, Agilent Technologies, Fluidigm Corporation, Pacific Biosciences, Agios Pharmaceuticals,

U.S. digital genome market size accounted for over 80% of the North American revenue in 2015, mainly due to the presence of established healthcare infrastructure and advanced facilities for effective treatment and care. The successful completion of Human Genome Project (HGP) has attracted significant public and private initiatives, driving the business growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/1219

In 2015, Germany digital genome market size was valued at over USD 1.4 billion and is anticipated to witness considerable growth till 2024. Increasing investments by public and private companies for development of novel technologies should boost digital genome industry growth.

China digital genome market is set to witness over 10% CAGR owing to favorable government initiative for development of human genetic resources platform and increasing collaboration among research institutes for creation of genomic databases and biobanks.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:

1.Sigma-Aldrich
2.Thermo Fisher Scientific
3.PerkinElmer, Inc.
4.QIAGEN
5.BioMarin Pharmaceutical Inc.
6.Illumina
7.Agilent Technologies
8.Fluidigm Corporation
9.Pacific Biosciences
10.Agios Pharmaceuticals
11.AVEO Oncology

Biotechnology innovation has enabled development of genetically modified organisms (GMOs) in order to introduce specific improvements or traits. Successful production and commercialization of such modified organisms should stimulate business growth. Extensive applications in clinical diagnosis and research will also contribute to industry growth.

Effective disease management strategies for chronic ailments and growing number of private and public investments and grants are forecast to propel digital genome market growth over the forecast years.
Bio-pharmaceutical companies accounted for over 45% of digital genome market share due to increasing demand for targeted drug therapy. Growing usage trend for precision medicines should provide lucrative growth opportunities for segment growth.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1219

Digital Genome Market By Product
• Sequencing & Analyzer Instruments
• DNA/RNA Analysis Kits
• Sequencing Chips
• Sequencing & Analysis Software
• Sample Prep Instruments

Digital Genome Market By Application
• Microbiology
• Reproductive & Genetic
• Transplantation
• Livestock and Agriculture
• Forensics
• Research and Development

Digital Genome Market By End-Use
• Diagnostics & Forensic Labs
• Academic Research Institutes
• Hospitals
• Bio-pharmaceutical companies

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.